Kevin Church - Net Worth and Insider Trading
Kevin Church Net Worth
The estimated net worth of Kevin Church is at least $49,910 dollars as of 2024-12-27. Kevin Church is the CHIEF SCIENTIFIC OFFICER of Athira Pharma Inc and owns about 92,684 shares of Athira Pharma Inc (ATHA) stock worth over $49,910. Details can be seen in Kevin Church's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Church has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Church
Kevin Church Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Church owns 1 companies in total, including Athira Pharma Inc (ATHA) .
Click here to see the complete history of Kevin Church’s form 4 insider trades.
Insider Ownership Summary of Kevin Church
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-09-05 | Vice President of Discovery |
Kevin Church Latest Holdings Summary
Kevin Church currently owns a total of 1 stock. Kevin Church owns 92,684 shares of Athira Pharma Inc (ATHA) as of September 5, 2024, with a value of $49,910.
Latest Holdings of Kevin Church
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-09-05 | 92,684 | 0.54 | 49,910 |
Holding Weightings of Kevin Church
Kevin Church Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Church has made a total of 4 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Athira Pharma Inc is the sale of 2,525 shares on September 5, 2024, which brought Kevin Church around $1,439.
Insider Trading History of Kevin Church
- 1
Kevin Church Trading Performance
Kevin Church Ownership Network
Kevin Church Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Kevin Church is the Vice President of Discovery of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Chief Technology Officer Rachel Lenington .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Kevin Church made 2 insider transaction in Athira Pharma Inc (ATHA) with a net sale of 4,937. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net sale of 14,672 shares made by Mark James Litton , a net sale of 7,349 shares made by Mark Worthington , and a net sale of 7,349 shares made by Rachel Lenington .
In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,787 shares of Athira Pharma Inc (ATHA) were sold and 648,086 shares were bought by its insiders, resulting in a net purchase of 611,299 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Kevin Church Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Church. You might contact Kevin Church via mailing address: 4000 Mason Road, Suite 300, Box 352141, Seattle Wa 98195-2141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
